113 related articles for article (PubMed ID: 8844788)
1. The effect of SM-8849 on experimental arthritis in mice.
Nagai H; Takaoka Y; Kuwabara K; Kamada H; Kitagaki K
Pharmacology; 1996 Jun; 52(6):377-86. PubMed ID: 8844788
[TBL] [Abstract][Full Text] [Related]
2. The effects of mesoporphyrin on experimental arthritis in mice.
Nagai H; Takaoka Y; Mori H; Matsuura N
Inflamm Res; 1996 Jun; 45(6):293-8. PubMed ID: 8814461
[TBL] [Abstract][Full Text] [Related]
3. The model of arthritis induced by superantigen in mice.
Nagai H; Takaoka Y; Kamada H; Mori H
Life Sci; 1994; 55(12):PL233-7. PubMed ID: 8057748
[TBL] [Abstract][Full Text] [Related]
4. Suppression of murine collagen-induced arthritis by treatment with a novel thiazole derivative, SM-8849.
Nishikaku F; Koga Y
Immunopharmacology; 1993; 25(1):65-74. PubMed ID: 8320081
[TBL] [Abstract][Full Text] [Related]
5. Type II collagen-induced murine arthritis. II. Genetic control of arthritis induction is expressed on L3T4+ T cells required for humoral as well as cell-mediated immune responses to type II collagen.
Seki N; Sudo Y; Yamane A; Sugihara S; Takai Y; Ishihara K; Ono S; Hamaoka T; Senoh H; Fujiwara H
Reg Immunol; 1989; 2(4):203-12. PubMed ID: 2577123
[TBL] [Abstract][Full Text] [Related]
6. The effect of TRK-530 on experimental arthritis in mice.
Takaoka Y; Nagai H; Mori H; Tanahashi M
Biol Pharm Bull; 1997 Nov; 20(11):1147-50. PubMed ID: 9401721
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of D-penicillamine and a thiazole derivative, SM-8849, on pristane-induced arthritis in mice.
Nishikaku F; Aono S; Koga Y
Int J Immunopharmacol; 1994 Feb; 16(2):91-100. PubMed ID: 7514159
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis.
Germann T; Hess H; Szeliga J; Rüde E
Ann N Y Acad Sci; 1996 Oct; 795():227-40. PubMed ID: 8958934
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcal enterotoxin B induces arthritis in female DBA/1 mice but fails to induce activation of type II collagen-reactive lymphocytes.
Omata S; Sasaki T; Kakimoto K; Yamashita U
Cell Immunol; 1997 Aug; 179(2):138-45. PubMed ID: 9268497
[TBL] [Abstract][Full Text] [Related]
10. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
11. Effect of KE-298 on experimental arthritis in mice.
Nagai H; Takaoka Y; Mori H; Kawada K
Pharmacology; 1996 Sep; 53(3):190-6. PubMed ID: 8931104
[TBL] [Abstract][Full Text] [Related]
12. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.
Morgan ME; Sutmuller RP; Witteveen HJ; van Duivenvoorde LM; Zanelli E; Melief CJ; Snijders A; Offringa R; de Vries RR; Toes RE
Arthritis Rheum; 2003 May; 48(5):1452-60. PubMed ID: 12746920
[TBL] [Abstract][Full Text] [Related]
13. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.
Seki N; Sudo Y; Yoshioka T; Sugihara S; Fujitsu T; Sakuma S; Ogawa T; Hamaoka T; Senoh H; Fujiwara H
J Immunol; 1988 Mar; 140(5):1477-84. PubMed ID: 3257978
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A and FK-506 inhibit development of superantigen-potentiated collagen-induced arthritis in mice.
Takaoka Y; Nagai H; Tanahashi M; Kawada K
Gen Pharmacol; 1998 May; 30(5):777-82. PubMed ID: 9559334
[TBL] [Abstract][Full Text] [Related]
15. Delayed type hypersensitivity (DTH) to type II collagen (CII) in DBA-1 mice.
Farmer LM; Watt G; Glatt M; Blaettler A; Loutis N; Feige U
Clin Exp Immunol; 1986 Aug; 65(2):329-35. PubMed ID: 3491709
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immunologic aspects of adjuvant and collagen arthritis in rats.
Panosian N; Heyner S; Capetola RJ; Orzechowski RF
J Immunopharmacol; 1986; 8(3):347-70. PubMed ID: 3639116
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of suppression of arthritis in the mouse model of collagen-induced arthritis. Evidence for a type II collagen-specific suppressor T cell.
Kresina TF; Moskowitz RW
J Clin Invest; 1985 Jun; 75(6):1990-8. PubMed ID: 3159755
[TBL] [Abstract][Full Text] [Related]
18. Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice.
Nagai H; Matsuura S; Bouda K; Takaoka Y; Wang T; Niwa S; Shudo K
Pharmacology; 1999 Feb; 58(2):101-12. PubMed ID: 9873234
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
20. In vivo analysis of a superantigen-induced T cell suppressor factor.
Hu HL; Cornwell WD; Rogers TJ; Lin YS
Cell Immunol; 1996 Feb; 167(2):285-92. PubMed ID: 8603438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
